openPR Logo
Press release

Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pectoris Drug Market: Strategic Insights Driving Angina Pectoris Drugs Market Momentum in 2025

09-12-2025 09:43 AM CET | Health & Medicine

Press release from: The Business Research Company

Angina Pectoris Drugs

Angina Pectoris Drugs

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Angina Pectoris Drugs Market Size By 2025?
The market size for angina pectoris drugs has experienced consistent growth in the past few years. The market is projected to expand from $12.32 billion in 2024 to $12.88 billion in 2025, representing a compound annual growth rate (CAGR) of 4.5%. The market's past growth can be credited to factors such as the high occurrence of cardiovascular diseases, an aging population, lifestyle-related factors, a rise in hypertension levels, and the prevalence of diabetes.

How Big Is the Angina Pectoris Drugs Market Size Expected to Grow by 2029?
The market size for drugs used to treat angina pectoris is predicted to experience significant expansion in the upcoming years, with estimations indicating a rise to "$16.42 billion in 2029" at a CAGR of 6.3%. Factors contributing to this projected growth during the forecasted period include a surge in global obesity numbers, progress in precision medicine, a shift towards preventive cardiology, initiatives for educating patients, and research into new therapeutic targets. Key trends anticipated during this period comprise telemedicine for distant patient monitoring, real-world evidence and outcomes studies, patient-focused medication instruction, strategic partnerships to facilitate market access, progressive regulatory measures, and fast-tracked approvals.

View the full report here:
https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Which Key Market Drivers Powering Angina Pectoris Drugs Market Expansion and Growth?
The rise in cardiovascular diseases (CVD) is expected to fuel the advancement of the angina pectoris drug market. Cardiovascular diseases comprise a variety of disorders striking the heart and blood vessels; this includes ailment such as coronary artery disease, high blood pressure, heart failure, and strokes. Multiple factors contribute to the growing prevalence of CVDs, including an aging demographic, unhealthy habits, and the widespread issue of obesity. Medications for angina pectoris, including nitrates, beta-blockers, and calcium channel blockers, effectively assuage the chest pain and discomfort that arise from inadequate blood circulation to the heart, consequently improving the overall quality of life for patients. For instance, data released by the British Heart Foundation, a UK-based cardiovascular research charity in September 2024, demonstrated that nearly 7.6 million people suffer from heart and circulatory diseases in the UK, approximately 4 million of which are males and 3.6 million are females. These diseases account for around 27% of all annual mortalities in the UK, approximating to over 170,000 deaths a year, or about 480 deaths per day, which is equal to a death every three minutes. As a result, the rising incidence of cardiovascular diseases is fueling the expansion of the angina pectoris drug market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp

What Are the Key Trends Driving Angina Pectoris Drugs Market Growth?
The prominent trend in the angina pectoris drugs market is product innovation. Most leading firms in the marketplace are turning towards novel technologies to maintain their market position. For example, Hikma Pharmaceuticals PLC, a pharmaceutical firm based in the UK, launched a product named Labetalol Hydrochloride Injection, USP, in a prefilled syringe in March 2023. The US Food and Drug Administration has approved this product. This product is in use predominantly in hospitals, through a 10 mg/2 mL PFS, to address severe hypertension and to reduce blood pressure.

What Are the Emerging Segments in the Angina Pectoris Drugs Market?
The angina pectoris drugs market covered in this report is segmented -

1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs
2) By Indication: Stable Angina, Unstable Angina, Prinzmetal's Angina
3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates
2) By Antiplatelet Agents: Aspirin, Clopidogrel
3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers
4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers
5) By Anti-Ischemic Agents: Ranolazine, Ivabradine
6) By Statins: Atorvastatin, Rosuvastatin

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10797&type=smp

Who Are the Global Leaders in the Angina Pectoris Drugs Market?
Major companies operating in the angina pectoris drugs market include Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AERIE PHARMACEUTICALS INC., AbbVie Inc., Amgen Inc., Gilead Sciences Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Ipsen S.A., Lupin Pharmaceuticals Inc., Merck KGaA, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Servier Laboratories, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A.

Which are the Top Profitable Regional Markets for the Angina Pectoris Drugs Industry?
North America was the largest region in the angina pectoris drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10797

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pectoris Drug Market: Strategic Insights Driving Angina Pectoris Drugs Market Momentum in 2025 here

News-ID: 4180576 • Views:

More Releases from The Business Research Company

Pharmaceutical Pellets Market Trends That Will Shape the Next Decade: Insights from Product Innovations Transforming The Pharmaceutical Pellets Market
Pharmaceutical Pellets Market Trends That Will Shape the Next Decade: Insights f …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Pharmaceutical Pellets Market Size By 2025? The market size for pharmaceutical pellets has seen rapid expansion in recent years. The market value is expected to increase from $1.82 billion in 2024 to $2.01 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.1%.
Key Trends Influencing the Growth of the Crohn's Disease Treatment Market in 2025: Innovating New Drugs To Transform The Crohn's Disease Treatment Landscape
Key Trends Influencing the Growth of the Crohn's Disease Treatment Market in 202 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Crohn's Disease Treatment Market Through 2025? There has been significant expansion in the size of the market for treatment of Crohn's disease in the last few years. It is anticipated to rise from $12.45 billion in 2024 to $13.1 billion in 2025,
Rising Ophthalmic Disorders Fueling Growth In Ophthalmic Drug Market: Powering Innovation and Expansion in the Ophthalmic Drugs Market by 2025
Rising Ophthalmic Disorders Fueling Growth In Ophthalmic Drug Market: Powering I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Ophthalmic Drugs Market Through 2025? In recent years, the ophthalmic drugs market has witnessed robust growth. It is projected to escalate from $39.36 billion in 2024 to $42.25 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The growth
Increasing Incidence Of Chronic Lymphocytic Leukemia Drives Growth In The Cll Market: Pivotal Factor Influencing Chronic Lymphocytic Leukemia Treatment Market Growth in 2025
Increasing Incidence Of Chronic Lymphocytic Leukemia Drives Growth In The Cll Ma …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Chronic Lymphocytic Leukemia Treatment Market Size Growth Forecast: What to Expect by 2025? There has been a robust growth in the market for chronic lymphocytic leukemia treatment in recent years. The market size is estimated to increase from $14.41 billion in 2024 to $15.58 billion in 2025, with a

All 5 Releases


More Releases for Angina

Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina
Key Influencer in the Angina Pectoris Drugs Market Outlook 2025: Surging Prevale …
What market dynamics are playing a key role in accelerating the growth of the angina pectoris drugs market? The surge in cardiovascular diseases is anticipated to kick-start the expansion of the angina pectoris drug market. The scope of cardiovascular diseases includes diverse disorders affecting the heart and blood vessels, such as stroke, coronary artery disease, hypertension, and heart failure. The rising prevalence of cardiovascular diseases (CVD) is linked to numerous elements,
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market? The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina. Angina is caused due to the built
Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow to